Daxor (DXR) Insider Trading & Ownership $8.14 +0.02 (+0.25%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Daxor (NASDAQ:DXR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage59.00%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$33,804.80Number OfInsiders Selling(Last 12 Months)0 Get DXR Insider Trade Alerts Want to know when executives and insiders are buying or selling Daxor stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DXR Insider Buying and Selling by Quarter Remove Ads Daxor Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/10/2025Michael Richard FeldschuhCEOBuy3,360$7.68$25,804.80 3/10/2025Robert J MichelCFOBuy1,000$8.00$8,000.00 (Data available from 1/1/2013 forward) DXR Insider Trading Activity - Frequently Asked Questions Who is on Daxor's Insider Roster? The list of insiders at Daxor includes Michael Richard Feldschuh, and Robert J Michel. Learn more on insiders at DXR. What percentage of Daxor stock is owned by insiders? 59.00% of Daxor stock is owned by insiders. Learn more on DXR's insider holdings. Which Daxor insiders have been buying company stock? The following insiders have purchased DXR shares in the last 24 months: Michael Richard Feldschuh ($48,595.70), and Robert J Michel ($24,400.00). How much insider buying is happening at Daxor? Insiders have purchased a total of 9,138 DXR shares in the last 24 months for a total of $72,995.70 bought. Daxor Key ExecutivesMr. Jonathan Adam Feldschuh (Age 59)Chief Scientific Officer & Director Compensation: $127.92kMr. Michael Richard Feldschuh (Age 55)Chairman, President & CEO Compensation: $100k1 recent tradesMr. Robert J. Michel CPA (Age 67)CPA, M.B.A., CFO, Chief Compliance Officer & Corporate Secretary 1 recent tradesMs. Linda CooperVice President of Development & OperationsMs. Kathryn A. KornafelSenior VP of Marketing & Commercial DevelopmentMr. Guido ManzoVice President of SalesMs. Jean OertelSenior Vice President Commercialization & Customer ExperienceDr. John Lynn Jefferies FACCM.B.A., M.D., M.P.H., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies LENSAR Insider Trades Perspective Therapeutics Insider Trades Pro-Dex Insider Trades Orchestra BioMed Insider Trades Sight Sciences Insider Trades Neuronetics Insider Trades InfuSystem Insider Trades KORU Medical Systems Insider Trades Lucid Diagnostics Insider Trades FONAR Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:DXR) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
